The risk of developing rare blood clots is even lower when receiving a second dose of the AstraZeneca COVID-19 vaccine, with experts reiterating that the benefits outweigh the risk in Canada’s race to get inoculated.

168 thoughts on “Risks of rare blood clot even lower with second dose of AstraZeneca, experts say”

Leave a Comment

Your email address will not be published. Required fields are marked *